PTC Therapeutics Presents New Sepiapterin Data from Ongoing Studies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 60.66 -0.41 (0.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $61.07 | 52 Week High | $35.40 | |||
| Open | $61.07 | 52 Week Low | $4.03 | |||
| Day High | $61.50 | P/E | 6.45 | |||
| Day Low | $59.87 | EPS | $9.40 | |||
| Volume | 380,530 | |||||
